Skip to main content
Premium Trial:

Request an Annual Quote

PGx and Biomarker Research Will Feature in Expanded J&J Facility in Pa.

NEW YORK (GenomeWeb News) — Johnson & Johnson Pharmaceutical Research and Development is expanding its facilities in Spring House, Pa., that will house drug-development research into biomarkers, structural biology, and pharmacogenomics, the company said yesterday.
 
The new facility, expected to be completed in 2009, will add around 150,000 square feet to the Spring House complex. The company said it plans to keep the 680 employees on the campus, and said it expects to hire 120 more.  

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.